Antitrust Antitrust

Lexon tells court UK regulator misanalyzed drugmakers' talks over antidepressant supply

By Simon Zekaria
  • 19 Nov 2020 11:46
  • 19 Nov 2020 12:17

Lexon told a judge today that the UK competition authority's enforcers wrongly analyzed the content and context of discussions between drug companies over the market supply of an antidepressant medication.

The drugmaker, which is appealing a Competition and Markets Authority decision from earlier this year, said the communication, spanning text messages,

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News